In a study performed by Wang et al. [246], the PAMAM dendrimer was modified with triazine-containing polymers as a strategy for efficient tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) gene therapy of osteosarcoma [246]. Here, TNF is linked to osteosarcoma.